Year: 2016
Type: review
Abstract: Multidrug resistance (MDR) presents a serious challenge to the efficiency of cancer treatment, and may be associated with the overexpression of drug efflux pumps. P-glycoprotein (P-gp) is a drug efflux pump often found overexpressed in cases of acquired MDR. Nevertheless, there are no P-gp inhibitors being used in the current clinical practice, due to toxicity problems, drug interactions, or pharmacokinetic issues. Therefore, it is important to identify novel inhibitors of P-gp activity or expression. Curcumin is a secondary metabolite isolated from the turmeric of Curcuma longa L. which has been associated with several biological activities, particularly P-gp modulatory activity (by inhibiting both P-gp function and expression). However, curcumin shows extensive metabolism and instability, which has justified the recent and intensive search for analogs of curcumin that maintain the P-gp modulatory activity but have enhanced stability. This review summarizes and compares the effects of curcumin and several curcumin analogs on P-glycoprotein function and expression, emphasizing the potential of these molecules for the possible development of safe and effective inhibitors of P-gp to overcome MDR in human cancer.
Source: Pharmaceuticals
DOI: 10.3390/ph9040071
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,499
Awards: G1009998704, G1314954773, G1452531853, G1516346500, G1578237752, G1763632427, G1795752003, G198576669, G323769159, G3840324753, G3891694003, G4316116677, G4724859719, G491858407, G498092695, G5224927334, G5321319778, G5485649731, UID/BIM/04293 .: Instituto de Investigação e Inovação em Saúde, UNDERSTANDING THE MOLECULAR MECHANISMS AND IDENTIFYING NOVEL INHIBITORS OF P-GP MEDIATED CANCER DRUG RESISTANCE, G7584003722, G8856833459, G96847669
OpenAlex ID: W2551712480
